Verona Pharma (VRNA)
60.44
1.90 (3.25%)
At close: Apr 02, 2025, 3:59 PM
58.54
-3.14%
After-hours: Apr 02, 2025, 07:57 PM EDT
Verona Pharma Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | Dec 31, 2005 |
| Revenue | 42.28M | n/a | 458K | 40M | n/a | 2.35K | 2.78K | 1.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 2.58M | 679.62K | 346K | n/a | 627.85K | 512.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 39.7M | -679.62K | 112K | 40M | -627.85K | -509.76K | 2.78K | 1.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -154.63M | -67.83M | -66.12M | -73.31M | -74.28M | -53.87M | -32.47M | -40.21M | -8.66M | -13.29M | -5.9M | -4.64M | -4.18M | -2.87M | -2.93M | -2.6M | -2.17M | -2.61M | -1.31M | -12.04K |
| Interest Income | 15.26M | 12.81M | 2.82M | 14K | 121K | 988.62K | 1.09M | 466.24K | 106.78K | 66.36K | 46.66K | 4.34K | 32.61K | 6.21K | 12.35K | 11.32K | 203.55K | 192.36K | 123.43K | 56.78K |
| Pretax Income | -163.13M | -55.21M | -68.45M | -55.59M | -65M | -51.41M | -30.62M | -34.06M | -7.37M | -13.22M | -5.86M | -4.64M | -4.15M | -2.86M | -2.91M | -2.59M | -1.97M | -2.41M | -1.19M | 44.74K |
| Net Income | -173.42M | -54.37M | -68.7M | -55.57M | -65.15M | -41.88M | -25.25M | -27.7M | -6.19M | -10.99M | -4.29M | -4.16M | -4.07M | -2.67M | -2.92M | -2.59M | -2.01M | -2.41M | -1.19M | 44.74K |
| Selling & General & Admin | 149.75M | 49.87M | 26.58M | 33.91M | 29.77M | 8.99M | 7.99M | 8.1M | 2.89M | 2.51M | 1.8M | 1.91M | 1.47M | 1.12M | 1.09M | 1.05M | 827.39K | 894.4K | 1.05M | 18.93K |
| Research & Development | 44.57M | 17.28M | 49.28M | 79.41M | 44.51M | 43.89M | 24.48M | 32.05M | 5.58M | 10.76M | 4.1M | 2.73M | 2.71M | 1.46M | 1.78M | 1.53M | 1.29M | 1.5M | 266.45K | n/a |
| Other Expenses | n/a | n/a | -9.63M | -15.63M | -8.27M | 527.09K | 16.5K | 23K | 1.07M | 1.17M | n/a | n/a | 0.00 | 268.6K | 43.22K | 11.32K | 61.51K | 196.33K | n/a | -113.57K |
| Operating Expenses | 194.32M | 67.15M | 66.23M | 97.68M | 66.01M | 53.41M | 32.48M | 40.16M | 8.49M | 13.29M | 5.9M | 4.64M | 4.18M | 2.87M | 2.93M | 2.6M | 2.17M | 2.61M | 1.31M | 12.04K |
| Interest Expense | 23.54M | 2.06M | 521K | 340K | 35K | 221.59K | n/a | 98.65K | 104.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | 19.38M | 22.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 196.91M | 67.83M | 66.57M | 97.68M | 66.01M | 53.41M | 32.48M | 40.16M | 8.49M | 13.29M | 5.9M | 4.64M | 4.18M | 2.87M | 2.93M | 2.6M | 2.17M | 2.61M | 1.31M | 12.04K |
| Income Tax | 10.29M | -632.44K | 253K | -18K | 146K | -9.53M | -5.37M | -6.36M | -1.18M | -2.24M | -1.56M | -477.22K | -77.68K | -192.52K | 7.72K | -24.25K | 41K | 192.36K | 123.43K | n/a |
| Shares Outstanding (Basic) | 652.31M | 604.1M | 528.46M | 473.18M | 262.93M | 105.32M | 105.1M | 87.74M | 33.5M | 20.19M | 17.33M | 6.82M | 6.13M | 6.14M | 6.14M | 6.14M | 6.14M | 6.14M | 6.14M | 6.14M |
| Shares Outstanding (Diluted) | 652.31M | 634.14M | 529.07M | 473.19M | 262.93M | 105.33M | 105.11M | 87.75M | 33.5M | 20.2M | 17.33M | 6.83M | 6.13M | 6.14M | 6.14M | 6.14M | 6.14M | 6.14M | 6.14M | 6.14M |
| EPS (Basic) | -0.27 | -0.09 | -0.13 | -0.12 | -0.25 | -0.4 | -0.24 | -0.32 | -0.18 | -0.54 | -0.25 | -0.61 | -0.66 | -0.43 | -0.48 | -0.42 | -0.33 | -0.39 | -0.19 | 0.01 |
| EPS (Diluted) | -0.27 | -0.09 | -0.13 | -0.12 | -0.25 | -0.4 | -0.24 | -0.32 | -0.18 | -0.54 | -0.25 | -0.61 | -0.66 | -0.43 | -0.48 | -0.42 | -0.33 | -0.39 | -0.19 | 0.01 |
| EBITDA | -138.53M | -52.47M | -67.29M | -42.19M | -47.81M | -32.17M | -25.5M | -29.64M | -6.96M | -8.92M | -3.74M | -2.78M | -2.56M | -2.86M | -2.88M | -2.59M | -1.94M | -2.39M | -1.19M | -12.04K |
| EBIT | -139.59M | -53.15M | -67.93M | -55.25M | -48.27M | -32.55M | -25.59M | -29.76M | -7.02M | -8.98M | -3.79M | -2.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Depreciation & Amortization | 1.06M | 679.62K | 636K | 629K | 627.85K | 512.11K | 124.35K | 166.22K | 76.03K | 78.69K | 82.43K | 61.99K | 49.08K | 37.26K | 32.41K | 35.57K | 27.82K | 27.76K | 3.92K | n/a |